192 related articles for article (PubMed ID: 38447616)
1. Therapeutic potential of traditional Chinese medicine in the prevention and treatment of digestive inflammatory cancer transformation: Portulaca oleracea L. as a promising drug.
Shao G; Liu Y; Lu L; Wang L; Ji G; Xu H
J Ethnopharmacol; 2024 Jun; 327():117999. PubMed ID: 38447616
[TBL] [Abstract][Full Text] [Related]
2. A review of traditional uses, phytochemistry and pharmacology of Portulaca oleracea L.
Iranshahy M; Javadi B; Iranshahi M; Jahanbakhsh SP; Mahyari S; Hassani FV; Karimi G
J Ethnopharmacol; 2017 Jun; 205():158-172. PubMed ID: 28495602
[TBL] [Abstract][Full Text] [Related]
3. A review on ethnopharmacology, phytochemistry, pharmacology and potential uses of Portulaca oleracea L.
Li K; Xia T; Jiang Y; Wang N; Lai L; Xu S; Yue X; Xin H
J Ethnopharmacol; 2024 Jan; 319(Pt 2):117211. PubMed ID: 37739100
[TBL] [Abstract][Full Text] [Related]
4. Network pharmacology based research into the effect and potential mechanism of Portulaca oleracea L. polysaccharide against ulcerative colitis.
Yang Y; Zhou X; Jia G; Li T; Li Y; Zhao R; Wang Y
Comput Biol Med; 2023 Jul; 161():106999. PubMed ID: 37216777
[TBL] [Abstract][Full Text] [Related]
5. Portulaca oleracea L.: a review of phytochemistry and pharmacological effects.
Zhou YX; Xin HL; Rahman K; Wang SJ; Peng C; Zhang H
Biomed Res Int; 2015; 2015():925631. PubMed ID: 25692148
[TBL] [Abstract][Full Text] [Related]
6. Determination of flavonoids in Portulaca oleracea L. by capillary electrophoresis with electrochemical detection.
Xu X; Yu L; Chen G
J Pharm Biomed Anal; 2006 May; 41(2):493-9. PubMed ID: 16516429
[TBL] [Abstract][Full Text] [Related]
7. Portulaca oleracea extracts and their active compounds ameliorate inflammatory bowel diseases in vitro and in vivo by modulating TNF-α, IL-6 and IL-1β signalling.
Kim Y; Lim HJ; Jang HJ; Lee S; Jung K; Lee SW; Lee SJ; Rho MC
Food Res Int; 2018 Apr; 106():335-343. PubMed ID: 29579933
[TBL] [Abstract][Full Text] [Related]
8. Exploring natural products-based cancer therapeutics derived from egyptian flora.
El-Seedi HR; Yosri N; Khalifa SAM; Guo Z; Musharraf SG; Xiao J; Saeed A; Du M; Khatib A; Abdel-Daim MM; Efferth T; Göransson U; Verpoorte R
J Ethnopharmacol; 2021 Apr; 269():113626. PubMed ID: 33248183
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the anti-inflammatory material basis of Lagotis brachystachya in HepG2 and THP-1 cells.
Zhu JX; Guo MX; Zhou L; Yi LT; Huang HL; Wang HL; Cheng HY
J Ethnopharmacol; 2024 Jan; 318(Pt B):117055. PubMed ID: 37597676
[TBL] [Abstract][Full Text] [Related]
10. Traditional Chinese medicine for pulmonary fibrosis therapy: Progress and future prospects.
Li LC; Kan LD
J Ethnopharmacol; 2017 Feb; 198():45-63. PubMed ID: 28038955
[TBL] [Abstract][Full Text] [Related]
11. Ameliorative effects of Portulaca oleracea L. (purslane) on the metabolic syndrome: A review.
Jalali J; Ghasemzadeh Rahbardar M
J Ethnopharmacol; 2022 Dec; 299():115672. PubMed ID: 36064150
[TBL] [Abstract][Full Text] [Related]
12. Traditional Chinese medicine formulas for the treatment of osteoporosis: Implication for antiosteoporotic drug discovery.
Zhang ND; Han T; Huang BK; Rahman K; Jiang YP; Xu HT; Qin LP; Xin HL; Zhang QY; Li YM
J Ethnopharmacol; 2016 Aug; 189():61-80. PubMed ID: 27180315
[TBL] [Abstract][Full Text] [Related]
13. The Hepato-protective Effects of Portulaca oleracea L. extract: Review.
Farkhondeh T; Samarghandian S; Azimi-Nezhad M; Hozeifi S
Curr Drug Discov Technol; 2019; 16(2):122-126. PubMed ID: 29600768
[TBL] [Abstract][Full Text] [Related]
14. Chinese herbal medicine-derived compounds for cancer therapy: a focus on hepatocellular carcinoma.
Hu Y; Wang S; Wu X; Zhang J; Chen R; Chen M; Wang Y
J Ethnopharmacol; 2013 Oct; 149(3):601-12. PubMed ID: 23916858
[TBL] [Abstract][Full Text] [Related]
15. Experimental and clinical studies on the effects of Portulaca oleracea L. and its constituents on respiratory, allergic, and immunologic disorders, a review.
Khazdair MR; Saadat S; Aslani MR; Shakeri F; Boskabady MH
Phytother Res; 2021 Dec; 35(12):6813-6842. PubMed ID: 34462981
[TBL] [Abstract][Full Text] [Related]
16. Deciphering the Effective Constituents and Mechanisms of
He X; Hu Y; Liu W; Zhu G; Zhang R; You J; Shao Y; Li Y; Zhang Z; Cui J; He Y; Ge G; Yang H
Front Pharmacol; 2021; 12():818227. PubMed ID: 35126150
[TBL] [Abstract][Full Text] [Related]
17. Plumeria rubra L.- A review on its ethnopharmacological, morphological, phytochemical, pharmacological and toxicological studies.
Bihani T
J Ethnopharmacol; 2021 Jan; 264():113291. PubMed ID: 32841700
[TBL] [Abstract][Full Text] [Related]
18. Advances in anti hepatic fibrotic therapy with Traditional Chinese Medicine herbal formula.
Li H
J Ethnopharmacol; 2020 Apr; 251():112442. PubMed ID: 31891799
[TBL] [Abstract][Full Text] [Related]
19. Autophagy modulators from traditional Chinese medicine: Mechanisms and therapeutic potentials for cancer and neurodegenerative diseases.
Wang SF; Wu MY; Cai CZ; Li M; Lu JH
J Ethnopharmacol; 2016 Dec; 194():861-876. PubMed ID: 27793785
[TBL] [Abstract][Full Text] [Related]
20. Medicine for chronic atrophic gastritis: a systematic review, meta- and network pharmacology analysis.
Weng J; Wu XF; Shao P; Liu XP; Wang CX
Ann Med; 2023; 55(2):2299352. PubMed ID: 38170849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
